Experimental vaccine completely protects cynomolgus macaques against lethal Sudan virus

Corporate businessmen working on tablet at office

A National Institutes of Health research group with extensive experience studying ebolavirus countermeasures has successfully developed a vaccine against Sudan virus (SUDV) based on the licensed Ebola virus (EBOV) vaccine.

Penn scientists discover a cellular pathway that keeps Ebola virus from exiting human cells

Previous article

MIT study helps shed light on why the immune system mounts a dull response to lung cancer

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News